Press Releases on October 21, 2024 - EIN Presswire - Press Release Distribution Service

Published on October 21, 2024 - 12:00 GMT

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab ...

FDA sets a PDUFA target action date of March 20, 2025 Resubmission is supported by the final survival analysis of CARES-310 study, presented at ASCO 2024 FORT LEE, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 21, 2024 - 12:00 GMT

Cyabra to Present at the ThinkEquity Conference in New York City on October 30

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Cyabra Strategy Ltd. (“Cyabra”), a leading provider of an AI-powered solution for combating worldwide disinformation, today announced that Dan Brahmy, Chief Executive Officer and Co-Founder, will present in …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on October 21, 2024 - 12:00 GMT

Windtree To Present at the ThinkEquity Conference on October 30th

WARRINGTON, Pa., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on October 21, 2024 - 12:00 GMT

5E Advanced Materials Reports Steady State Operations and Obtains Tax Exclusion For Lithium Capex

HESPERIA, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, is …

Distribution channels: Chemical Industry, Media, Advertising & PR ...

Published on October 21, 2024 - 12:00 GMT

Life Biosciences Presents at AAO Highlighting Progress of Nonhuman Primate Studies Evaluating Partial Epigenetic Reprogramming to ...

BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury and ultimately restore health for patients, today announced new …

Distribution channels: Technology ...

Published on October 21, 2024 - 12:00 GMT

Lancaster Resources Provides Corporate Update

VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR | OTC:LANRF | FRA:6UF0) (the “Company” or “Lancaster”) is pleased to provide a corporate update. The Company’s portfolio of projects includes the Piney Lake …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on October 21, 2024 - 12:00 GMT

Taseko Mines Provides Construction Update for Florence Copper

VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE MKT: TGB; LSE: TKO) ("Taseko" or the "Company") is pleased to provide a progress update for construction activities at its Florence …

Distribution channels:

Published on October 21, 2024 - 12:00 GMT

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on October 21, 2024 - 12:00 GMT

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024

SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business …

Distribution channels:

Published on October 21, 2024 - 12:00 GMT

Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced with deep sadness the …

Distribution channels: Companies, Technology ...

Published on October 21, 2024 - 12:00 GMT

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host ...

WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 21, 2024 - 12:00 GMT

Preferred Bank Reports Third Quarter Results

LOS ANGELES, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), one of the larger independent California banks, today reported results for the quarter ended September 30, 2024. Preferred Bank (“the Bank”) reported net income of $33.4 million …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 21, 2024 - 12:00 GMT

Diamond Equity Research Initiates Coverage on Solowin Holdings (NASDAQ:SWIN)

New York, New York, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Solowin Holdings (NASDAQ: SWIN). The in-depth 39-page initiation …

Distribution channels: Banking, Finance & Investment Industry, Science ...

Published on October 21, 2024 - 12:00 GMT

Immunohistochemistry Market to Grow at USD 5.5 Billion by 2031 | SkyQuest Technology

Westford, USA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Immunohistochemistry Market size was valued at around USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024–2031). Rising use of automation and …

Distribution channels: Companies, Media, Advertising & PR ...

Published on October 21, 2024 - 12:00 GMT

SERB Pharmaceuticals expands leading emergency care portfolio with acquisition of Aurlumyn™ (iloprost IV) for severe frostbite

Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn™ (iloprost IV), the only FDA approved treatment option for severe frostbite in the US, from …

Distribution channels: Companies, Media, Advertising & PR ...

Published on October 21, 2024 - 12:00 GMT

Orgenesis Commences Trading on OTCQX® Best Market

Reports Plans to Reapply for Nasdaq Listing Announces Progress Advancing Decentralized Cell Processing Platform GERMANTOWN, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company …

Distribution channels: Banking, Finance & Investment Industry ...

Published on October 21, 2024 - 12:00 GMT

VERSES and Volvo Cars Demonstrate Pedestrian Vehicle Safety Advancement

VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQX:VRSSF) ("VERSES" or the "Company”), a cognitive computing company specializing in next generation intelligent systems, today announces the …

Distribution channels: Companies, Media, Advertising & PR ...

Published on October 21, 2024 - 12:00 GMT

Biden-Harris Administration Announces Preliminary Terms with Hemlock Semiconductor to Significantly Expand U.S. Production ...

Today, the Biden-Harris Administration announced that the U.S. Department of Commerce and Hemlock Semiconductor (HSC) have signed a non-binding preliminary memorandum of terms (PMT) to provide up to $325 million in proposed direct funding under the CHIPS …

Distribution channels: Technology

Published on October 21, 2024 - 11:58 GMT

Cell & Gene Therapy Bioanalytical Testing Services Market on Track to Achieve USD 950.06 Mn Value with a 7.3% CAGR

The growing existence of detrimental illnesses such as cancer, which require enduring cures, is driving the market demand. NEW YORK CITY, NY, UNITED STATES, October 21, 2024 /⁨EINPresswire.com⁩/ -- Our cell & gene therapy bioanalytical testing …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 21, 2024 - 11:56 GMT

Data Integration Market to Witness 13.5% CAGR by 2031 | SkyQuest Technology

Westford, USA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Data Integration Market will attain the value of USD 38.20 billion by 2031, with a CAGR of 13.5% during the forecast period (2024-2031). Data integration is the process of combining …

Distribution channels: Companies, Media, Advertising & PR ...